About
Neta Lavon is Co-Founder and Chief Technology Officer of Aleph Farms, holding a Ph.D. and more than 20 years of experience in biotechnology, with work spanning stem cell science, cultivated meat, and clinical-stage programs in areas such as ALS and diabetes. She led the research and regulatory strategy behind the first regulatory approval of a cultivated beef product and has managed multidisciplinary teams of over 60 scientists and engineers. Her record includes securing over $144M in equity financing and building an IP portfolio of 13 published patent families and 5 pending applications.
Co-founder & CTO at Aleph Farms
Intro paths
→
In turn, Neta can intro founders to Aleph Farms's investors below.
Aleph Farms's investors · 10
Alumni VenturesManchester · $100K – $10M checksBasecamp FundManchester · $100K – $10M checksBloom8New YorkCastor Ventures (an Alumni Ventures Fund)Cockpit InnovationTel AvivCPT CapitalLondonL CattertonGreenwich · $10M – $200M checks · since 2025Peregrine VenturesOr Yehuda · $500K – $3M checksStray Dog CapitalLeawood · $100K – $1M checksUnovis Asset ManagementSan Francisco
Co-founders at Aleph Farms
SL
Shulamit LevenbergCo-founder
DT
Didier ToubiaCo-founder & CEO
Experience
- Aleph FarmsCo-Founder and Chief Technology Officercurrent2022 — present
- Aleph FarmsCo-Founder & Vice President of Research and Development2017 — 2022Israel
- KadimastemVice President of Operations2015 — 2017Nes Ziona
- KadimastemHead of the pluripotent stem cell unit2009 — 2017Nes Ziona, Israel
- KadimastemDirector of project management2013 — 2014Nes Ziona, Israel
- Cedars-Sinai Medical CenterResearch Scientist2006 — 2008Los Angeles Metropolitan Area
- Gamida Cell Ltd.Research assistant in the R&D team1999 — 2000Jerusalem, Israel
Skills & more
Executive Biotechnology Leadership1Stem Cells & Cell Therapy1CMC Development & Technology Scale-Up1Biopharma Corporate Strategy & FundraisingTranslational R&D StrategyBiotechnology32Stem Cells43Cell Culture19Cell Based Assays2Drug Discovery7Diabetes2Hepatology2
+12 more
Cellular ManufacturingCell TherapycGMP manufacturingEmbryonic Stem CellsCell BiologyCellMolecular BiologyLifesciencesTissue CultureIn VivoGeneticsLaboratoryFrom Neta's professional profile.
Frequently asked questions
- Who is Neta Lavon?
- Neta Lavon is Co-Founder and Chief Technology Officer of Aleph Farms, holding a Ph.D. and more than 20 years of experience in biotechnology, with work spanning stem cell science, cultivated meat, and clinical-stage programs in areas such as ALS and diabetes. She led the research and regulatory strategy behind the first regulatory approval of a cultivated beef product and has managed multidisciplinary teams of over 60 scientists and engineers. Her record includes securing over $144M in equity financing and building an IP portfolio of 13 published patent families and 5 pending applications.
- Where does Neta Lavon work?
- Neta Lavon is Co-founder & CTO of Aleph Farms.
- What companies did Neta Lavon found?
- Neta Lavon founded Aleph Farms.
- Where did Neta Lavon go to school?
- Neta Lavon studied at The Hebrew University of Jerusalem (Post doctoral fellow, Stem Cells and genetics); The Hebrew University of Jerusalem (Ph.D., Stem Cells); The Hebrew University of Jerusalem (Master of Science (MSc), Biotechnology).
Same school
Also attended The Hebrew University of Jerusalem236
Lisa CohenInvestment Director at Intel CapitalMiri FentonAssociate at Maverick Ventures IsraelTamar YehoshuaInvestor at IVP (Institutional Venture Partners)Rutie AdarInvestments & Innovation Sr. Director, Israel at Samsung Catalyst FundJack LevyInvestor at Israel Cleantech VenturesRony Patishi-ChillimInvestor at Israel Cleantech Ventures
+ 230 more
Shared employers
Also worked at Aleph Farms2
Also worked at Cedars-Sinai Medical Center21
Trevor BaglinInvestor at MedicxiEric MartonSenior Fund Advisor at Wavemaker Three-Sixty HealthMonica JainVenture Partner at Wavemaker Three-Sixty HealthSherwin KuoInvestor at FusionDeborah PalestrantPartner, Executive Chair, 4:59 Initiative at 5AM VenturesVikash SinghPrincipal at STILLMARK
+ 15 more